Kat Long
About Kat Long
Kat Long is the Director of External Research Grants, Medical Operations & Alliances at Alkermes, with over a decade of experience in the biotech and pharmaceutical industries, focusing on medical affairs and clinical research.
Current Role at Alkermes
Kat Long currently serves as the Director of External Research Grants, Medical Operations & Alliances at Alkermes. She has been leading the External Research Grants, Medical Operations & Alliances arm since July 2019. Her role involves overseeing the management of research grants while fostering collaborations and alliances in the medical sector.
Previous Experience at Vertex Pharmaceuticals
Prior to her current role at Alkermes, Kat Long accumulated extensive experience at Vertex Pharmaceuticals. From 2012 to 2018, she undertook various roles, starting as a Clinical Trials Associate and advancing to Clinical Trials Manager, Manager of Global Medical Affairs, and finally, Senior Manager of Independent Research in Global Medical Affairs. During her tenure, she was responsible for managing clinical trials and contributing to global medical research initiatives.
Early Career and Previous Positions
Kat Long began her career at ECOG-ACRIN Cancer Research Group (formerly ECOG), where she held positions as a Group Meetings Assistant and Industry Liaison from 2005 to 2011. She then moved to Synta Pharmaceuticals, where she worked as a Clinical Research Specialist from 2011 to 2012, before joining Vertex Pharmaceuticals.
Educational Background
Kat Long holds a Master of Science degree in Regulatory Affairs for Drugs, Biologics, and Medical Devices from Northeastern University. Additionally, she earned a Bachelor of Arts degree in Communications from Westfield State University. Her educational background has equipped her with in-depth knowledge of regulatory affairs and strong communication skills.
Expertise in Medical Operations and Alliances
With over a decade of experience in the biotech and pharmaceutical industries, Kat Long has developed a comprehensive expertise in medical operations and alliances. She has managed clinical trials, overseen research grants, and led collaborative efforts within these sectors, making significant contributions to the advancement of medical research and development.